Dark

NBIX
Neurocrine Biosciences Inc
stock NASDAQ

At Close

Sep 25, 2026 3:59:59 PM EDT

138.20USD-0.536%(-0.74)1,145,466

130.16Bid 152.90Ask 22.74Spread

Pre-market

Sep 25, 2026 8:01:30 AM EDT

139.00USD+0.043%(+0.06)2,404

After-hours

Sep 25, 2026 4:30:30 PM EDT

138.40USD+0.148%(+0.20)2,070

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

14.08B

CEO

Kevin Gorman

Headquarters

San Diego, California, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Oct 27, 2026 (32d)

RGEN ATHX LLY PFE PTN ABBV ANIP CASI PRTK XLV

NBIX Stats

Avg. Vol. 10 Day

1,353,537

Avg. Vol. 30 Day

1,179,746

Employees

470

Market Cap

14,081,461,044

Shares Out.

101,649,181

On/Off Exchange

58%/42%

6 Month Beta

0.48

1 Year Beta

0.64

2 Year Beta

0.79

3 Year Beta

0.71

52 Week Low

122.14

52 Week High

186.12

SMA50

159.62

SMA200

147.69

1 Week

-5.27%

1 Month

-9.68%

3 Month

-15.62%

6 Month

+5.64%

1 Year

-1.68%

2 Year

+20.93%

5 Year

+45.84%

Profile

neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders

NBIX Stock Summary

Neurocrine Biosciences Inc (NASDAQ:NBIX) stock price today is $138.20, and today's volume is 1,145,466. NBIX is down -0.536% today. The 30 day average volume is 1,179,746. NBIX market cap is 14.08B with 101,649,181 shares outstanding.